Search

everythinglearnresearchcommunity

for

Search:↓

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Phage therapy could be a safe and effective new treatment for acne.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

PRP shows promise in treating urological diseases but needs more research.

Dutasteride may help shrink prostate cancer tumors.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Finasteride improves urinary function in men for 2 years.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Pharmacists play a crucial role in patient care and optimizing treatment outcomes.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.